Literature DB >> 11705324

Renal osteodystrophy.

E A González1, K J Martin.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11705324     DOI： 10.1023/a:1010058828232

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  51 in total

1.  Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3.

Authors:  S G Massry; R Stein; J Garty; A I Arieff; J W Coburn; A W Norman; R M Friedler
Journal:  Kidney Int       Date:  1976-06       Impact factor: 10.612

2.  Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.

Authors:  H Yi; M Fukagawa; H Yamato; M Kumagai; T Watanabe; K Kurokawa
Journal:  Nephron       Date:  1995       Impact factor: 2.847

3.  Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.

Authors:  C Christiansen; M S Christensen; F Melsen; P Rødbro; H F DeLuca
Journal:  Clin Nephrol       Date:  1981-01       Impact factor: 0.975

4.  RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate.

Authors:  E Moallem; R Kilav; J Silver; T Naveh-Many
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

5.  Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.

Authors:  T Naveh-Many; R Marx; E Keshet; J W Pike; J Silver
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia.

Authors:  L D Quarles; B Lobaugh; G Murphy
Journal:  J Clin Endocrinol Metab       Date:  1992-07       Impact factor: 5.958

7.  19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.

Authors:  K J Martin; E A González; M Gellens; L L Hamm; H Abboud; J Lindberg
Journal:  J Am Soc Nephrol       Date:  1998-08       Impact factor: 10.121

8.  Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3.

Authors:  M B Demay; M S Kiernan; H F DeLuca; H M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

9.  Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity.

Authors:  C H Hsu; S Patel
Journal:  J Am Soc Nephrol       Date:  1992-10       Impact factor: 10.121

10.  Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

Authors:  M Wang; G Hercz; D J Sherrard; N A Maloney; G V Segre; Y Pei
Journal:  Am J Kidney Dis       Date:  1995-11       Impact factor: 8.860
View more
  3 in total

1.  Use of renal function measurements for assessing fracture risk in postmenopausal women.

Authors:  James T McCarthy; Andrew D Rule; Sara J Achenbach; Eric J Bergstralh; Sundeep Khosla; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2008-11       Impact factor: 7.616

2.  Long-term fracture risk following renal transplantation: a population-based study.

Authors:  Line M Vautour; L Joseph Melton; Bart L Clarke; Sara J Achenbach; Ann L Oberg; James T McCarthy
Journal:  Osteoporos Int       Date:  2003-12-09       Impact factor: 4.507

3.  New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy.

Authors:  Magdalena Krintus; Agnieszka Pater; Gra Yna Sypniewska; Wies Aw Nowacki
Journal:  EJIFCC       Date:  2004-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.